Oxfordshire Clinical Commissioning Group
Formulary
 
back
10 Musculoskeletal and joint diseases
10-01 Drugs used in rheumatic diseases and gout

Belimumab Benlysta®
Formulary

For the treatment of active autoantibody-positive systemic lupus erythematosus as per NICE TA397.

Funded by specialised commissioning.

APCO July 2016.

Link  NICE TA397: Belimumab for treating active autoantibody-positive systemic lupus erythematosus
 

Red View adult BNF  View SPC online  View childrens BNF  HCD